The company dedicated to discovering vaccines for herpes is back in the news. Rational Vaccines gained notoriety when its founder, the late Dr. Bill Halford, bypassed FDA protocol for vaccine development and set up a small trial on the island of St. Kitts, in the Caribbean, using live attenuated virus on volunteers who were suffering from herpes simplex. Now, three years after Dr. Halford's death, Rational is developing five vaccines for herpes and two for COVID. But his time, by the book.
Of all the drugs used to treat herpes, acyclovir is the most common. So, how does it work? The devil is in the details ... and the details are fascinating.
A cure for herpes? Finally? Synergy Pharmaceuticals claims it has one. The FDA did not agree. Who's right? Take a wild guess.
Everyone knows by now that astronauts get more herpes outbreaks. Big deal. But did you ever consider what a game-changer this could be for those who might accidentally pick up a little contagion while seeking pleasure outside the marriage? No more "I got it from the toilet seat." Now you have a better excuse. Will you join this club, 62 miles up?
Tea tree oil is one of the most popular (and profitable) fads around right now. The Internet is bursting with health claims for just about every malady known to mankind. Could it be useful for treating herpes? Maybe. Here's a lesson in how antiviral drugs are discovered.
There's never been a therapeutic vaccine for any infectious disease, and there isn't one on the horizon. But there are plenty of drugs that work quite well for infections: antibiotics, antifungals and antivirals.
Vical continues to push its VCL-HB01 herpes vaccine through development. Larry Smith, Ph.D., the senior VP of Research, answers some questions about where things stand now and what to expect in the near future.
Over nearly a century, vaccines for genital herpes have come and gone. Make that gone and gone, because there's not a single vaccine that can treat or prevent either oral or genital herpes. But some good news might be coming from Vical, when phase II results of its VCL-HB01 vaccine is released, hopefully in mid-2018.
For those of you who are following herpes vaccines in development, the news out of Australia isn't bad. Or especially good. Admedus just released Phase IIa clinical trial results of its herpes simplex 2 vaccine. Even the company didn't seem all that enthusiastic (which is, in a way, OK.)
We are really starchemotherapyting to get creative in the way we treat cancer. In April we brought you the story of researchers who used the polio virus to treat brain cancer. Earlier this month we discussed some big advances in personalized medicine drugs and last week we discus
A group of researchers from Umea University in Sweden published two related studies in their attempt to explore a link between infection